Descriptions and Benefits
SR9009, also known as Stenabolic, is a SARM that was developed at the Scripps Research Institute. It is a PPAR alpha modifier very similar GW-501516. It binds to the Rev-erbα protein, which influences lipid and glucose metabolism in the liver and the creation of fat-storing cells.
Stenabolic has been found to increase mitochondria, the powerhouses of your cells. Once mice were given Stenabolic, they were able to run for 50% longer than non-treated mice. It has also been found to aid weight loss.
10MG per tab
There are no known side effects, including no known suppression of endogenous testosterone as Stenabolic is not a hormonal drug.